Literature DB >> 23174209

Inhibition of phosphodiesterase-5 rescues age-related impairment of synaptic plasticity and memory.

Agostino Palmeri1, Lucia Privitera, Salvatore Giunta, Carla Loreto, Daniela Puzzo.   

Abstract

Aging is characterized by a progressive cognitive decline that leads to memory impairment. Because the cyclic nucleotide cascade is essential for the integrity of synaptic function and memory, and it is down-regulated during aging and in neurodegenerative disorders, we investigated whether an increase in cGMP levels might rescue age-related synaptic and memory deficits in mice. We demonstrated that acute perfusion with the phosphodiesterase-5 inhibitor sildenafil (50 nM) ameliorated long-term potentiation in hippocampal slices from 26-30-month-old mice. Moreover, chronic intraperitoneal injection of sildenafil (3mg/kg for 3 weeks) improved age-related spatial learning and reference memory as tested by the Morris Water Maze, and recognition memory as tested by the Object Recognition Test. Finally, sildenafil restored central cAMP responsive element-binding protein (CREB) phosphorylation, which is crucial for synaptic plasticity and memory. Our data suggest that inhibition of phosphodiesterase-5 may be beneficial to treat age-related cognitive dysfunction in a physiological mouse model of aging.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23174209     DOI: 10.1016/j.bbr.2012.10.060

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  24 in total

1.  Amyloid-β Peptide Is Needed for cGMP-Induced Long-Term Potentiation and Memory.

Authors:  Agostino Palmeri; Roberta Ricciarelli; Walter Gulisano; Daniela Rivera; Claudia Rebosio; Elisa Calcagno; Maria Rosaria Tropea; Silvia Conti; Utpal Das; Subhojit Roy; Maria Adelaide Pronzato; Ottavio Arancio; Ernesto Fedele; Daniela Puzzo
Journal:  J Neurosci       Date:  2017-06-16       Impact factor: 6.167

Review 2.  Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.

Authors:  Michy P Kelly
Journal:  Cell Signal       Date:  2017-11-23       Impact factor: 4.315

3.  Furoxans (Oxadiazole-4 N-oxides) with Attenuated Reactivity are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory.

Authors:  Austin Horton; Kevin Nash; Ethel Tackie-Yarboi; Alexander Kostrevski; Adam Novak; Aparna Raghavan; Jatin Tulsulkar; Qasim Alhadidi; Nathan Wamer; Bryn Langenderfer; Kalee Royster; Maxwell Ducharme; Katelyn Hagood; Megan Post; Zahoor A Shah; Isaac T Schiefer
Journal:  J Med Chem       Date:  2018-05-07       Impact factor: 7.446

Review 4.  Rodent models for Alzheimer's disease drug discovery.

Authors:  Daniela Puzzo; Walter Gulisano; Agostino Palmeri; Ottavio Arancio
Journal:  Expert Opin Drug Discov       Date:  2015-04-30       Impact factor: 6.098

Review 5.  Age-Related Neurodegeneration Prevention Through mTOR Inhibition: Potential Mechanisms and Remaining Questions.

Authors:  Jordan B Jahrling; Remi-Martin Laberge
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

6.  Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease.

Authors:  Giuseppina Cantarella; Giulia Di Benedetto; Daniela Puzzo; Lucia Privitera; Carla Loreto; Salvatore Saccone; Salvatore Giunta; Agostino Palmeri; Renato Bernardini
Journal:  Brain       Date:  2014-12-02       Impact factor: 13.501

7.  Improved long-term memory via enhancing cGMP-PKG signaling requires cAMP-PKA signaling.

Authors:  Eva Bollen; Daniela Puzzo; Kris Rutten; Lucia Privitera; Jochen De Vry; Tim Vanmierlo; Gunter Kenis; Agostino Palmeri; Rudi D'Hooge; Detlef Balschun; Harry M W Steinbusch; Arjan Blokland; Jos Prickaerts
Journal:  Neuropsychopharmacology       Date:  2014-05-12       Impact factor: 7.853

Review 8.  Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.

Authors:  Daniela Puzzo; Linda Lee; Agostino Palmeri; Giorgio Calabrese; Ottavio Arancio
Journal:  Biochem Pharmacol       Date:  2014-01-21       Impact factor: 5.858

Review 9.  Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease.

Authors:  Elisa Zuccarello; Erica Acquarone; Elisa Calcagno; Elentina K Argyrousi; Shi-Xian Deng; Donald W Landry; Ottavio Arancio; Jole Fiorito
Journal:  Biochem Pharmacol       Date:  2020-01-21       Impact factor: 5.858

Review 10.  New perspectives in cyclic nucleotide-mediated functions in the CNS: the emerging role of cyclic nucleotide-gated (CNG) channels.

Authors:  Maria Vittoria Podda; Claudio Grassi
Journal:  Pflugers Arch       Date:  2013-10-19       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.